Insider filing · PLSE

Paul A Laviolette bought $295K of Pulse Biosciences (PLSE)

Executed May 11, disclosed May 11, the same day.

Over the 21 trading sessions from the disclosed entry session (May 11), the stock returned +33.8% (delay-adjusted); from the execution session (May 11), +33.8%. Derived: entry at the session's open, exit at the close 20 sessions later.

PL Paul A Laviolette Chief Executive Officer profile →

Paul A Laviolette (Chief Executive Officer) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in PLSE. Across 1 priced purchase filing, the average 21-session return was +33.8% from execution and +33.8% from disclosure (delay-adjusted; derived). The largest single filing was $295K of PLSE (15,000 sh × $19.69, as filed), executed May 11.

PLSE PLSE PLSE · 15 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→